BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4331443)

  • 1. Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission.
    Simpson LL
    Neuropharmacology; 1971 Nov; 10(6):673-84. PubMed ID: 4331443
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the presynaptic actions of botulinum toxin and beta-bungarotoxin on neuromuscular transmission.
    Chang CC; Huang MC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):129-42. PubMed ID: 4368526
    [No Abstract]   [Full Text] [Related]  

  • 3. The interaction between divalent cations and botulinum toxin type A in the paralysis of the rat phrenic nerve-hemidiaphragm preparation.
    Simpson LL
    Neuropharmacology; 1973 Feb; 12(2):165-76. PubMed ID: 4362622
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparation.
    Simpson LL
    Neuropharmacology; 1974 Aug; 13(8):683-91. PubMed ID: 4444755
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin.
    Habermann E; Dreyer F; Bigalke H
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):33-40. PubMed ID: 6245375
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of botulinum toxin paralysis by low temperature.
    Lundh H
    Muscle Nerve; 1983 Jan; 6(1):56-60. PubMed ID: 6302501
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs affecting transmitter release from motor nerve terminals.
    Thesleff S
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):80-2. PubMed ID: 4297759
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Affinity labelling" of the cholinergic receptor of the motor end plate with diazoacetylcholine].
    Waser PG; Hofmann A; Hopff W
    Experientia; 1970 Dec; 26(12):1342-3. PubMed ID: 4321673
    [No Abstract]   [Full Text] [Related]  

  • 9. The binding of botulinum toxin to membrane lipids: phospholipids and proteolipid.
    Simpson LL; Rapport MM
    J Neurochem; 1971 Sep; 18(9):1761-7. PubMed ID: 4936887
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation between nerve-muscle transmission and nerve trophic effects on rat diaphragm using type D botulinum toxin.
    Bray JJ; Harris AJ
    J Physiol; 1975 Dec; 253(1):53-77. PubMed ID: 54420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of calcium and magnesium on the rate of onset of botulinum toxin paralysis of the rat diaphragm.
    Simpson LL; Tapp JT
    Int J Neuropharmacol; 1967 Nov; 6(6):485-92. PubMed ID: 4870164
    [No Abstract]   [Full Text] [Related]  

  • 12. The prejunctional inhibitory effect of suramin on neuromuscular transmission in vitro.
    Henning RH; Rowan EG; Braga MF; Nelemans A; Harvey AL
    Eur J Pharmacol; 1996 Apr; 301(1-3):91-7. PubMed ID: 8773451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of botulinum toxin to membrane lipids: sphingolipids, steroids and fatty acids.
    Simpson LL; Rapport MM
    J Neurochem; 1971 Sep; 18(9):1751-9. PubMed ID: 4936886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paralysis of the anterior tibial muscle of the rat by the central action of botulinum toxin].
    Silva AJ
    Arch Farmacol Toxicol; 1979 Dec; 5(3):180-2. PubMed ID: 232648
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum toxin type A: kinetics of calcium dependent paralysis of the neuromuscular junction and antagonism by drugs and animal toxins.
    Metezeau P; Desban M
    Toxicon; 1982; 20(3):649-54. PubMed ID: 6125045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
    Simpson LL
    Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
    Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
    J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and transmitter release.
    Cohen I; Van der Kloot W
    Int Rev Neurobiol; 1985; 27():299-336. PubMed ID: 2867980
    [No Abstract]   [Full Text] [Related]  

  • 19. The neuromuscular blocking action of gentamicin.
    Vital Brazil O; Prado-Franceschi J
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):65-77. PubMed ID: 4311767
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic-induced paralysis of the mouse phrenic nerve-hemidiaphragm preparation, and reversibility by calcium and by neostigmine.
    Singh YN; Harvey AL; Marshall IG
    Anesthesiology; 1978 Jun; 48(6):418-24. PubMed ID: 208426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.